Fabienne Lamballe

Marseille, 13009, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer.

Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 05, 2025

Multi-omics profiling uncovers immune-molecular clusters with distinct chemo-immunotherapeutic vulnerabilities in a mouse model of triple-negative breast cancer.

Multi-omics profiling uncovers immune-molecular clusters with distinct chemo-immunotherapeutic vulnerabilities in a mouse model of triple-negative breast cancer.

Journal: Molecular cancer

Published: September 24, 2025

Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation.

Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation.

Journal: Redox biology

Published: July 19, 2025

Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling.

Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling.

Journal: Cells

Published: December 19, 2021

BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators.

BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators.

Journal: Theranostics

Published: March 16, 2021

Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance.

Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 10, 2020

Tracking Dynamics of Spontaneous Tumors in Mice Using Photon-Counting Computed Tomography.

Tracking Dynamics of Spontaneous Tumors in Mice Using Photon-Counting Computed Tomography.

Journal: iScience

Published: July 26, 2019

Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.

Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.

Journal: Oncotarget

Published: August 02, 2016

Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling.

Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling.

Journal: Cancer research

Published: February 09, 2015

Plasticity versus specificity in RTK signalling modalities for distinct biological outcomes in motor neurons.

Plasticity versus specificity in RTK signalling modalities for distinct biological outcomes in motor neurons.

Journal: BMC biology

Published: July 01, 2014

Combined drug action of 2-phenylimidazo[2,1-b]benzothiazole derivatives on cancer cells according to their oncogenic molecular signatures.

Combined drug action of 2-phenylimidazo[2,1-b]benzothiazole derivatives on cancer cells according to their oncogenic molecular signatures.

Journal: PloS one

Published: May 25, 2012

Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver.

Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver.

Journal: Journal of hepatology

Published: January 05, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026